Position in TEVA
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$82,559,612
-$2,418,475 QoQ
Shares Held
2,741,023
+0.7% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $1,198,425,266 across 43 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,965,717 | $350,577,405 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
190,697 | $113,079,505 | |
| 3 | HLN |
Haleon plc
|
8,699,093 | $87,077,919 | |
| 4 | ALKS |
Alkermes plc.
|
2,460,569 | $87,005,718 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
2,741,023 | $82,559,612 | |
| 6 | VTRS |
Viatris Inc
|
5,347,207 | $72,240,764 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
443,052 | $58,367,669 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
2,243,204 | $53,679,870 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,559,612 | 2,741,023 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $84,978,087 | 2,722,784 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $40,690,556 | 2,014,384 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $36,508,022 | 2,178,283 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $40,826,976 | 2,656,277 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||